Boston Scientific appoints Jonathan Monson as SVP Investor Relations; Emily Woodworth as CAO

BOSTON SCIENTIFIC CORP

Jonathan Monson appointed SVP Investor Relations effective March 1, 2024; will no longer serve as Chief Accounting Officer.
Emily Woodworth (Collins) appointed SVP Global Controller and CAO effective March 1, 2024; previously VP Finance and Controller of Urology business.
Woodworth will receive base salary, annual bonus, and incentive stock awards commensurate with officer level.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Emily Woodworth (Collins)

Senior Vice President, Global Controller and Chief Accounting Officer

BSX · BOSTON SCIENTIFIC CORP

Effective: 2024-03-01
Filed: January 31, 2024, 6:59 PM ET

Also on January 26, 2024, the Board appointed Emily Woodworth (Collins), age 46, as Senior Vice President, Global Controller and Chief Accounting Officer, effective March 1, 2024.

Role change

Jonathan Monson

Senior Vice President, Investor Relations

BSX · BOSTON SCIENTIFIC CORP

Effective: 2024-03-01
Successor: Emily Woodworth (Collins)
Filed: January 31, 2024, 6:59 PM ET

On January 26, 2024, the Board of Directors (the “Board”) of Boston Scientific Corporation (the “Company”) appointed Jonathan Monson as Senior Vice President, Investor Relations, effective March 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Emily Woodworth (Collins) was appointed as Senior Vice President, Global Controller and Chief Accounting Officer at BOSTON SCIENTIFIC CORP.

Action: appointed
Role: Senior Vice President, Global Controller and Chief Accounting Officer

Exact text from the filing

Also on January 26, 2024, the Board appointed Emily Woodworth (Collins), age 46, as Senior Vice President, Global Controller and Chief Accounting Officer, effective March 1, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jonathan Monson was appointed as Senior Vice President, Investor Relations at BOSTON SCIENTIFIC CORP.

Action: appointed
Role: Senior Vice President, Investor Relations

Exact text from the filing

On January 26, 2024, the Board of Directors (the “Board”) of Boston Scientific Corporation (the “Company”) appointed Jonathan Monson as Senior Vice President, Investor Relations, effective March 1, 2024.

View on SEC.gov

BOSTON SCIENTIFIC CORP filing history →

Source: SEC EDGAR

accession 0000885725-24-000014

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.